GU Cancers 2020 | Alison Birtle: ASCO GU highlights

Name: Alison Birtle: ASCO GU highlights
Uploaded: 2020-02-13T00:00:00.000Z
Duration: 1 min 53 s
Description: Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, outlines the key data from this year’s GU Cancers Symposium at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Alison Birtle • 13 Feb 2020

GU Cancers 2020

Bladder Cancer Genitourinary Cancer Prostate Cancer Abiraterone Cisplatin Docetaxel Gemcitabine Nintedanib Pembrolizumab

NEO-BLADE STAMPEDE

Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, outlines the key data from this year’s GU Cancers Symposium at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Disclosures

Alison Birtle, MRCP, FRCR, MD, has received research support from Sanofi Aventis, and has participated in advisory boards or provided educational support to Janssen, Astellas, Bayer, Roche, BMS, Pfizer, Sanofi Aventis and MSD.